Mark Goldsmith Insider Trades & Stock Holdings

President and Chief Executive Officer · Revolution Medicines, Inc. · Latest filing Jun 16, 2026

Mark Goldsmith, President and Chief Executive Officer at Revolution Medicines, Inc. has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.56M), net -$1.56M. Latest filing: disposed of 10.02K shares of $RVMD on Jun 16, 2026 at $156.12.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.56M

Net open-market

-$1.56M

Latest filing

Jun 16, 2026

All insider trades by Mark Goldsmith

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$RVMD	Sell (Open-market sale) 10b5-1	10.02K	$156.12	$1.56M			+8.3%	+14.4%		President and Chief Executive Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Mark Goldsmith traded

• $RVMD

Frequently asked questions

Has Mark Goldsmith been buying or selling stock?

Mark Goldsmith has 0 open-market purchases and 1 open-market sale on file, net -$1.56M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Mark Goldsmith's latest insider trade?

disposed of 10.02K shares of $RVMD on Jun 16, 2026 at $156.12.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.